Selected Journal
Articles
|
Marinova GV, Loyaga-Rendon RY, Obayashi S, Ishibashi T, Kubota T, Imamura M, Azuma H.
Possible involvement of altered arginase activity, arginase type I and type II expressions, and nitric oxide production in occurrence of intimal hyperplasia in premenopausal human uterine arteries.
J Pharmacol Sci. 2008 Mar;106(3):385-93. Epub 2008 Mar 5.
PMID: 18319562
Iwasaki-Kurashige K, Loyaga-Rendon RY, Matsumoto H, Tokunaga T, Azuma H.
Possible mediators involved in decreasing peripheral vascular resistance with blackcurrant concentrate (BC) in hind-limb perfusion model of the rat.
Vascul Pharmacol. 2006 Apr;44(4):215-23. Epub 2006 Jan 30.
PMID: 16448858
Loyaga-Rendon RY, Sakamoto S, Aso T, Iwasaki-Kurashige K, Takahashi R, Azuma H.
Mediators involved in decreasing peripheral vascular resistance with carbachol in the rat hind limb perfusion model.
J Pharmacol Sci. 2005 Jul;98(3):263-74. Epub 2005 Jul 9.
PMID: 16006739
Loyaga-Rendon RY, Sakamoto S, Beppu M, Aso T, Ishizaka M, Takahashi R, Azuma H.
Accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, attenuated dimethylarginine dimethylaminohydrolase activity and intimal hyperplasia in premenopausal human uterine arteries.
Atherosclerosis. 2005 Feb;178(2):231-9.
PMID: 15694929
|
